Novonesis (Novozymes) B (STU:NZM2)
€ 56.62 0.52 (0.93%) Market Cap: 26.38 Bil Enterprise Value: 28.11 Bil PE Ratio: 39.62 PB Ratio: 2.44 GF Score: 97/100

Novozymes A/S Annual Shareholders Meeting Transcript

Feb 27, 2019 / 03:00PM GMT
Release Date Price: €46.42
JÃ;rgen Buhl Rasmussen;S;Chairman
Novozymes A

¸ - /-

I think we can now establish that those that wish to attend the meeting have arrived. So I'd like to start the meeting by saying dear shareholders, welcome once again, to the Super Arena in Ballerup to the Annual General Meeting of Novozymes 2019. We look forward to this afternoon's program and to invite you to join us for light refreshments afterwards.

Here you see our strong purpose statements. Since 2015, this is what has guided us. Translated into Danish, it says that together we'll find biological solutions that enable us to lead better lives in a growing world. This is not just a fancy statement that we devised because it sounds good. This is something that illustrates what we wish to achieve with our business and the effects our solutions will have on the planet and the people living on it. Our biological solutions, you see, may solve many of the global challenges that the world is facing today. Our purpose, strategy and long-term targets are well in keeping with the UN Sustainable Development

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot